Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-U.S. dollar slumps as equity markets rally; Fed in focus

Mon, 14th Sep 2020 15:20

* Suga set to succeed Abe as Japan PM, focus turns to new cabinet
* Dollar falls to two-week low vs yen
* Dollar under pressure ahead of Fed policy meeting outcome on Wed
* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

(Adds new comment, FX table, updates prices, changes byline, dateline; previous LONDON)
By Gertrude Chavez-Dreyfuss
NEW YORK, Sept 14 (Reuters) - The dollar slipped on Monday against its major peers, dropping to a
two-week low versus the yen, as positive news about a COVID-19 vaccine and a wave of merger and
acquisition deals lifted the mood in global equity markets.
Investors also looked ahead to an event-packed week which includes a Federal Reserve meeting and the
appointment of a new Japanese premier.
U.S. stocks rose on Monday on signs of progress in developing a COVID-19 vaccine and a flurry of
multibillion-dollar deals, including reports of Oracle winning the battle for the U.S. arm of
TikTok.
"As equities trade more positively at the start of the new week, the dollar is trading weaker again.
The market is still showing that it is likely to fade any dollar strength," said Vassili Serebriakov, FX
strategist at UBS in New York.
Global equities got a lift after drugmaker AstraZeneca resumed its British clinical trials of
its COVID-19 vaccine, one of the most advanced in development.
"As long as the market perceives that the market is moving in the right direction with the vaccine,
the dollar will weaken more as a cyclical play," Serebriakov added.
In morning trading, the dollar index fell 0.4% to 92.919, after posting two straight weeks of
gains.
This week's Fed Reserve meeting will be its first since Chairman Jerome Powell unveiled a policy shift
toward greater tolerance of inflation, effectively pledging to keep interest rates low for longer.
"There will be pressure on the Fed to back up the new policy goals with some action," said MUFG
strategist Lee Hardman, noting that inflation remained well below target.
"Expectations are they could strengthen forward guidance, possibly by saying rates will be on hold for
3-4 years," said Hardman, who remains bearish on the greenback.
Analysts at Standard Chartered said there was a risk the Fed would disappoint dollar bears.
Speculators trimmed net short dollar positions for the second straight week to $32.67 billion,
according to Reuters calculations and Commodity Futures Trading Commission data. That's off nine-year
highs of $33.68 billion in late August.
The dollar fell 0.5% against the yen to 105.66 yen, after earlier sliding to a two-week low.
The Bank of Japan's meeting on Thursday is not expected to yield any policy changes but the bank may
be quizzed on whether it could follow the Fed's inflation stance.
On the political front, Chief Cabinet Secretary Yoshihide Suga was picked to head Japan's ruling party
on Monday, meaning on Wednesday in parliament he is set to be selected by his peers as prime minister,
taking over from Shinzo Abe.
Suga has vowed to continue Abe's policies.
The euro was up 0.3% versus the dollar at $1.1880.
The single currency had spiked to a one-week high above $1.191 after Thursday's European Central Bank
meeting, before easing back as policymakers talked it down the next day.

========================================================
Currency bid prices at 10:10AM (1410 GMT)
Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid
Previous Change
Session
Euro/Dollar EUR= $1.1879 $1.1845 +0.29% +5.97% +1.1887 +1.1831
Dollar/Yen JPY= 105.6400 106.1400 -0.47% -2.96% +106.1900 +105.6400
Euro/Yen EURJPY= 125.51 125.75 -0.19% +2.92% +125.9000 +125.5300
Dollar/Swiss CHF= 0.9059 0.9086 -0.30% -6.40% +0.9098 +0.9060
Sterling/Dollar GBP= 1.2901 1.2793 +0.84% -2.70% +1.2918 +1.2778
Dollar/Canadian CAD= 1.3169 1.3174 -0.04% +1.41% +1.3196 +1.3154
Australian/Doll AUD= 0.7294 0.7283 +0.15% +3.89% +0.7295 +0.7265
ar
Euro/Swiss EURCHF= 1.0763 1.0764 -0.01% -0.82% +1.0775 +1.0761
Euro/Sterling EURGBP= 0.9206 0.9254 -0.52% +8.90% +0.9263 +0.9202
NZ NZD= 0.6707 0.6664 +0.65% -0.43% +0.6714 +0.6660
Dollar/Dollar
Dollar/Norway NOK= 8.9874 9.0336 -0.51% +2.38% +9.0531 +8.9861
Euro/Norway EURNOK= 10.6787 10.7024 -0.22% +8.55% +10.7121 +10.6716
Dollar/Sweden SEK= 8.7595 8.7687 +0.17% -6.29% +8.7881 +8.7539
Euro/Sweden EURSEK= 10.4090 10.3916 +0.17% -0.58% +10.4210 +10.3756


(Reporting by Gertrude Chavez-Dreyfuss; Additional reporting by Sujata Rao and Ritvik Carvalho in London;
editing by Jonathan Oatis)

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.